Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme.

[1]  L. Buée,et al.  Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis. , 2014, European journal of medicinal chemistry.

[2]  T. Terasaki,et al.  Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells. , 2013, Journal of Alzheimer's disease : JAD.

[3]  Shohei Koide,et al.  Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme , 2013, Proceedings of the National Academy of Sciences.

[4]  I. Hamley,et al.  Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic Aβ Peptide Aggregates , 2013, PloS one.

[5]  Amy L. Lane,et al.  Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity. , 2013, Journal of medicinal chemistry.

[6]  W. K. Schmidt,et al.  Cell-Permeable, Small-Molecule Activators of the Insulin-Degrading Enzyme , 2012, Journal of biomolecular screening.

[7]  F. Leroux,et al.  Novel selective inhibitors of neutral endopeptidase: discovery by screening and hit-to-lead optimisation , 2012 .

[8]  I. Kavakli,et al.  Structure Based Discovery of Small Molecules to Regulate the Activity of Human Insulin Degrading Enzyme , 2012, PloS one.

[9]  Hao Sun.  Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism. , 2012, Bioorganic & medicinal chemistry letters.

[10]  B. Déprez,et al.  Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation. , 2011, European journal of medicinal chemistry.

[11]  L. Hersh,et al.  Identification of the Allosteric Regulatory Site of Insulysin , 2011, PloS one.

[12]  T. Sosnick,et al.  Ubiquitin is a novel substrate for human insulin-degrading enzyme. , 2011, Journal of molecular biology.

[13]  R. Koenen,et al.  Polymerization of MIP‐1 chemokine (CCL3 and CCL4) and clearance of MIP‐1 by insulin‐degrading enzyme , 2010, The EMBO journal.

[14]  T. Funke,et al.  Insulin-degrading Enzyme Modulates the Natriuretic Peptide-mediated Signaling Response* , 2010, The Journal of Biological Chemistry.

[15]  D. Selkoe,et al.  Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin , 2010, PloS one.

[16]  Wei-Jen Tang,et al.  Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme. , 2010, Journal of molecular biology.

[17]  L. Morelli,et al.  Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease. , 2009, Current pharmaceutical design.

[18]  B. Déprez,et al.  Hydroxamates: relationships between structure and plasma stability. , 2009, Journal of medicinal chemistry.

[19]  Wei-Jen Tang,et al.  Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme* , 2009, Journal of Biological Chemistry.

[20]  D. Selkoe,et al.  Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening , 2009, PloS one.

[21]  M. Coletta,et al.  Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity. , 2009, Journal of molecular biology.

[22]  F. Leroux,et al.  Synthesis of a 200-member library of squaric acid N-hydroxylamide amides. , 2008, Bioorganic & medicinal chemistry letters.

[23]  E. Malito,et al.  Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin , 2008, Cellular and Molecular Life Sciences.

[24]  B. Déprez,et al.  Alkylsquarates as key intermediates for the rapid preparation of original drug-inspired compounds. , 2008, Combinatorial chemistry & high throughput screening.

[25]  Wei-Jen Tang,et al.  Structure of Substrate-free Human Insulin-degrading Enzyme (IDE) and Biophysical Analysis of ATP-induced Conformational Switch of IDE* , 2007, Journal of Biological Chemistry.

[26]  L. Hersh,et al.  The insulysin (insulin degrading enzyme) enigma , 2006, Cellular and Molecular Life Sciences CMLS.

[27]  M. Folstein,et al.  Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis , 2006, Neurobiology of Aging.

[28]  J. Kelly,et al.  Toward assessing the position-dependent contributions of backbone hydrogen bonding to beta-sheet folding thermodynamics employing amide-to-ester perturbations. , 2004, Journal of the American Chemical Society.

[29]  D. Selkoe,et al.  Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. , 2004, The American journal of pathology.

[30]  D. Selkoe,et al.  Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death , 2003, Neuron.

[31]  L. Feuk,et al.  Genetic variation in a haplotype block spanning IDE influences Alzheimer disease , 2003, Human mutation.

[32]  W. Duckworth,et al.  Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme. , 2003, The Journal of endocrinology.

[33]  Eugene Krissinel,et al.  The CCP4 molecular-graphics project. , 2002, Acta crystallographica. Section D, Biological crystallography.

[34]  A. Tartar,et al.  Parallel Synthesis of 1,2,4‐Oxadiazoles from Carboxylic Acids Using an Improved, Uronium‐Based, Activation. , 2001 .

[35]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[36]  H. Luthman,et al.  Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. , 2000, Human molecular genetics.

[37]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[38]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[39]  M. Pirrung,et al.  O-Alkyl Hydroxamates as Metaphors of Enzyme-Bound Enolate Intermediates in Hydroxy Acid Dehydrogenases. Inhibitors of Isopropylmalate Dehydrogenase, Isocitrate Dehydrogenase, and Tartrate Dehydrogenase(1). , 1996, The Journal of organic chemistry.

[40]  I. Kurochkin,et al.  Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme , 1994, FEBS letters.

[41]  H. Wasserman,et al.  Total Synthesis of Tetracycline. , 1986 .

[42]  J. Boothe,et al.  Total Synthesis of Tetracyclines.1 III.2 Synthesis of a Tricyclic Model System , 1961 .

[43]  M. MacCoss,et al.  Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism , 2006 .

[44]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[45]  R. Roth,et al.  Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme. , 1984, Endocrine research.

[46]  R. Brown,et al.  1,2,5-, 1,3,4- and 1,2,4-Oxadiazoles , 1968 .